K. Kubota

Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan

K. Tamura, M. Matsuoka, K. Imai, 2021, Journal of medical microbiology.

Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using the VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan

K. Tamura, M. Matsuoka, K. Imai, 2020, medRxiv.

Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities

Noriaki Arakawa, M. Matsuoka, K. Imai, 2021, International Journal of Infectious Diseases.

Evaluation of the correlation between the access SARS‐CoV‐2 IgM and IgG II antibody tests with the SARS‐CoV‐2 surrogate virus neutralization test

M. Matsuoka, S. Maesaki, N. Tarumoto, 2021, Journal of medical virology.

Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays

M. Matsuoka, S. Maesaki, J. Sakai, 2021, Diagnostic Microbiology and Infectious Disease.

Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan

K. Tamura, M. Matsuoka, S. Maesaki, 2020, medRxiv.

Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan

K. Tamura, M. Matsuoka, S. Maesaki, 2021, Journal of medical virology.